AVEO PHARMACEUTICALS, INC. reports

Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Boston, MA
SEC filing record 1 source field available
Fiscal year end
31 December
AVEO PHARMACEUTICALS, INC. has filed 1,019 SEC EDGAR filings since 27 Apr 2005

SEC filing history

Showing 726-750 of 1,000 matching filings.

Per page
25
Current page
30
8-K File 001-34655

FORM 8-K

Filing date
07 Jan 2013
Reporting date
07 Jan 2013
SEC evidence
Open document Open filing
Next action
Verify source filing
4

EPSTEIN FORM 4

Filing date
20 Dec 2012
Reporting date
18 Dec 2012
SEC evidence
Open document Open filing
Next action
Verify source filing
3

EPSTEIN FORM 3

Filing date
20 Dec 2012
Reporting date
18 Dec 2012
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-34655

FORM 8-K

Filing date
20 Dec 2012
Reporting date
18 Dec 2012
SEC evidence
Open document Open filing
Next action
Verify source filing
4

KUCHERLAPATI FORM 4

Filing date
17 Dec 2012
Reporting date
13 Dec 2012
SEC evidence
Open document Open filing
Next action
Verify source filing
4

TERMEER FORM 4

Filing date
14 Dec 2012
Reporting date
12 Dec 2012
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
14 Dec 2012
Reporting date
13 Dec 2012
SEC evidence
Open document Open filing
Next action
Verify source filing
4

HA-NGOC FORM 4

Filing date
14 Dec 2012
Reporting date
12 Dec 2012
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
04 Dec 2012
Reporting date
03 Dec 2012
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-34655

FORM 8-K

Filing date
30 Oct 2012
Reporting date
30 Oct 2012
SEC evidence
Open document Open filing
Next action
Verify source filing
4/A

ROBINSON FORM 4/A

Filing date
03 Oct 2012
Reporting date
28 Sep 2012
SEC evidence
Open document Open filing
Next action
Verify source filing
4

ROBINSON FORM 4

Filing date
02 Oct 2012
Reporting date
28 Sep 2012
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
14 Sep 2012
Reporting date
13 Sep 2012
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G File 005-85745

DISCLOSURE DOCUMENT

Filing date
10 Aug 2012
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
09 Aug 2012
Reporting date
08 Aug 2012
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-34655

FORM 8-K

Filing date
02 Aug 2012
Reporting date
02 Aug 2012
SEC evidence
Open document Open filing
Next action
Verify source filing
4

SLICHENMYER FORM 4

Filing date
18 Jul 2012
Reporting date
17 Jul 2012
SEC evidence
Open document Open filing
Next action
Verify source filing
4

SLICHENMYER FORM 4

Filing date
05 Jul 2012
Reporting date
03 Jul 2012
SEC evidence
Open document Open filing
Next action
Verify source filing
4

SLICHENMYER FORM 4

Filing date
21 Jun 2012
Reporting date
19 Jun 2012
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
12 Jun 2012
Reporting date
30 May 2012
SEC evidence
Open document Open filing
Next action
Verify source filing
3

VITTIGLIO FORM 3

Filing date
11 Jun 2012
Reporting date
30 May 2012
SEC evidence
Open document Open filing
Next action
Verify source filing
3

JONES FORM 3

Filing date
11 Jun 2012
Reporting date
30 May 2012
SEC evidence
Open document Open filing
Next action
Verify source filing
3

ROBINSON FORM 3

Filing date
11 Jun 2012
Reporting date
30 May 2012
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .